High cellularity and mitotic activity in a primary ovarian fibro-thecomatous tumor of a young patient: a diagnostic and clinical challenge

Purpose of Investigation: Solid ovarian tumors represent a clinical challenge, in particular in case of young patients who require a fertility sparing treatment. The authors report a case of hypercellular mitotically active ovarian fibrothecoma in a very young woman, successfully treated with a fertility sparing surgery. Materials and Methods: A 21-year-old nulliparous woman presented at the present hospital with a 14-cm right ovarian mass, consisting of solid and pseudo-cystic components. There was neither an elevation of tumor markers nor evidence of metastatic disease. A laparotomic right salpingo-oophorectomy was performed. Uterus and left adnexa were preserved. Results: The neoplasm consisted of a prevalent population of spindle-shaped elements and of a minor component of cells with wider cytoplasms, attributable to a thecomatous differentiation. The mitotic activity was focally elevated. Cytological atypia was mild to focally moderate. Clear areas of coagulative necrosis were not observed. At present 48 months after surgery, the patient is alive with no evidence of recurrence. Conclusions: The authors reported the lesion as a hypercellular and mitotically active fibrothecoma. The uneventful follow-up confirms the low malignant potential of the lesion. Caution is required reporting hypercellular stromal ovarian tumors, in order to avoid overdiagnosis and overtreatment, particularly in young patients.

Gynaecological oncology; General gynaecology; Gynaecological surgery.

[1] Prat J., Scully R.E.: “Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases”. Cancer, 1981, 47, 2663.

[2] Irving J.A., Alkushi A., Young R.H., Clement P.B.: “Cellular fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma”. Am. J. Surg. Pathol., 2006, 30, 929.

[3] Huang Y.C., Hsu K.F., Chou C.Y., Dai Y.C., Tzeng C.C.: “Ovarian fibrosarcoma with long-term survival: a case report”. Int. J. Gynecol. Cancer, 2001, 11, 331.

[4] Choi W.J., Ha M.T., Shin J.K., Lee J.H.: “Primary ovarian fibrosarcoma with long-term survival: a report of two cases”. J. Obstet. Gynaecol. Res., 2006, 32, 524.

[5] Huang L., Liao L.M., Wang H.Y., Zheng M.: “Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study”. BMC Cancer, 2010, 10, 585.

[6] Mellembakken J.R., Engh V., Tanbo T., Czernobilsky B., Edelstein E., Lunde O., Roth L.M.: “Mitotically active cellular luteinized thecoma of the ovary and luteinized thecomatosis associated with sclerosing peritonitis: case studies, comparison, and review of the literature”. Pathol. Res. Pract., 2010, 206, 744.

[7] McCluggage W.G., Sloan J.M., Boyle D.D., Toner P.G.: “Malignant fibrothecomatous tumour of the ovary: diagnostic value of anti-inhibin immunostaining”. J. Clin. Pathol., 1998, 51, 868.

[8] Kaku S., Takeshima N., Akiyama F., Furuta R., Hirai Y., Takizawa K.: “A unique fibrous tumor of the ovary: fibrosarcoma or mitotically active cellular fibroma?” Anticancer. Res., 2007, 27, 4365.